Objectives: This study compared the readability of patient education materials from the Turkish Ophthalmological Association (TOA) retinopathy of prematurity (ROP) guidelines with those generated by large language models (LLMs). The ability of GPT-4.0, GPT-4o mini, and Gemini to produce patient education materials was evaluated in terms of accuracy and comprehensiveness.
Materials And Methods: Thirty questions from the TOA ROP guidelines were posed to GPT-4.0, GPT-4o mini, and Gemini. Their responses were then reformulated using the prompts "Can you revise this text to be understandable at a 6-grade reading level?" (P1 format) and "Can you make this text easier to understand?" (P2 format). The readability of the TOA ROP guidelines and the LLM-generated responses was analyzed using the Ateşman and Bezirci-Yılmaz formulas. Additionally, ROP specialists evaluated the comprehensiveness and accuracy of the responses.
Results: The TOA brochure was found to have a reading level above the 6-grade level recommended in the literature. Materials generated by GPT-4.0 and Gemini had significantly greater readability than the TOA brochure (p<0.05). Adjustments made in the P1 and P2 formats improved readability for GPT-4.0, while no significant change was observed for GPT-4o mini and Gemini. GPT-4.0 had the highest scores for accuracy and comprehensiveness, while Gemini had the lowest.
Conclusion: GPT-4.0 appeared to have greater potential for generating more readable, accurate, and comprehensive patient education materials. However, when integrating LLMs into the healthcare field, regional medical differences and the accuracy of the provided information must be carefully assessed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707455 | PMC |
http://dx.doi.org/10.4274/tjo.galenos.2024.58295 | DOI Listing |
Ophthalmology
January 2025
Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA. Electronic address:
Purpose: To assess the utility of the first or second examinations for retinopathy of prematurity (ROP) in a medium-risk cohort of infants and to propose an optimization to the current ROP screening guidelines.
Design: Retrospective consecutive study.
Subjects: Infants screened for ROP between January 2017 and August 2023 at three different tertiary-level care neonatal intensive care units.
Clin Ophthalmol
January 2025
Magrabi Hospitals and Centers, Riyadh, Saudi Arabia.
Aim: This systematic review and meta-analysis aimed to evaluate the safety and efficacy of combined laser and anti-VEGF therapy for (retinopathy of prematurity ROP), focusing on both structural and functional outcomes.
Methods: A comprehensive search was conducted in multiple databases to identify randomized controlled trials (RCTs) that investigated combination therapy for ROP. The PRISMA guidelines were followed.
BMC Ophthalmol
January 2025
Department of Ophthalmology, Peking University People's Hospital, Beijing Key Laboratory of Ocular Disease and Optometry Science, Beijing, China.
Background: To analyze the demographic characteristics of retinopathy of prematurity (ROP) in China, attempting to propose optimized screening criteria and hopefully providing valuable information for future updates to the ROP guideline.
Methods: A multicenter, retrospective-cohort study was conducted. The study included infants born between January 1, 2018, and July 31, 2023, who underwent ROP screening and were diagnosed with ROP at seven screening centers in China.
Turk J Ophthalmol
December 2024
Mustafa Kemal University, Tayfur Sökmen Faculty of Medicine, Department of Ophthalmology, Hatay, Türkiye.
Turk J Med Sci
December 2024
Department of Ophthalmology, Faculty of Medicine, University of Health Sciences, Tepecik Research and Training Hospital, İzmir, Turkiye.
Background/aim: In Türkiye, the recommendations for screening for retinopathy of prematurity (ROP) were updated in 2021. We aimed to present detailed data on the infants included in the screening program according to the new criteria and evaluate whether these changes are of benefit in detecting severe ROP.
Materials And Methods: Our hospital's medical records of infants screened for ROP between July 2019 and July 2021 or between August 2021 and August 2023 were retrospectively examined.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!